← Back to Clinical Trials
Recruiting NCT05720507

NCT05720507 Preliminary Testing of Cafe Move for Primary Prevention of Physical Frailty

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05720507
Status Recruiting
Phase
Sponsor University of Montana
Condition Aging
Study Type INTERVENTIONAL
Enrollment 36 participants
Start Date 2023-04-29
Primary Completion 2027-02-01

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
Cafe Move

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 36 participants in total. It began in 2023-04-29 with a primary completion date of 2027-02-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This project explores a novel means of health promotion and prevention of age-related physical frailty, which is designed to overcome barriers to access and promote autonomy in managing physical health.

Eligibility Criteria

Inclusion Criteria: * Legally autonomous to consent * Lives independently * Ability to sit, stand, and walk without the assistance of another person Exclusion Criteria: * Not legally autonomous to consent * Institutionalized

Contact & Investigator

Central Contact

Andrew J Kittelson, PhD

✉ andy.kittelson@umontana.edu

📞 406-243-4015

Frequently Asked Questions

Who can join the NCT05720507 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, up to 85 Years, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05720507 currently recruiting?

Yes, NCT05720507 is actively recruiting participants. Contact the research team at andy.kittelson@umontana.edu for enrollment information.

Where is the NCT05720507 trial being conducted?

This trial is being conducted at Missoula, United States.

Who is sponsoring the NCT05720507 clinical trial?

NCT05720507 is sponsored by University of Montana. The trial plans to enroll 36 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology